Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Integra Lifesciences Q2 Adj. EPS $0.45 Beats $0.43 Estimate, Sales $415.605M Beat $395.067M Estimate

Author: Benzinga Newsdesk | July 31, 2025 05:04am
Integra Lifesciences (NASDAQ:IART) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0.43 by 4.17 percent. This is a 28.57 percent decrease over earnings of $0.63 per share from the same period last year. The company reported quarterly sales of $415.605 million which beat the analyst consensus estimate of $395.067 million by 5.20 percent. This is a 0.61 percent decrease over sales of $418.175 million the same period last year.

Posted In: IART


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist